Comparative Biochemistry of GH3, GH20 and GH84 β-N-acetyl-Dhexosaminidases and Recent Progress in Selective Inhibitor Discovery

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|13|4|512-525

ISSN： 1389-4501

Source： Current Drug Targets, Vol.13, Iss.4, 2012-04, pp. : 512-525

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Additive effect of GHRd3 and COLIA1 polymorphisms on the GH-substitution dose in GH-deficient adults

By Hartleb Silke Plöckinger Ursula Stalla Günter K Tuschy Ulrich Weber Matthias M Pfützner Andreas Kann Peter Herbert

Pharmacogenomics, Vol. 12, Iss. 12, 2011-12 ,pp. : 1653-1661

Future Medicine

Access to resources Recommend Favorite

The Importance of Growth Hormone (GH) and GH Secretagogues for Bone Mass and Density

Current Pharmaceutical Design, Vol. 8, Iss. 23, 2002-01 ,pp. : 2023-2032

Bentham Science Publishers

Access to resources Recommend Favorite

The Anabolic Effects of Growth Hormone (GH) and GH Secretagogues on Bone Mass and Density

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 1, 2005-02 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite

Long-term growth hormone (GH) therapy increases final height in GH-deficient and some non-GH-deficient children

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 20, Iss. 10, 2004-10 ,pp. : 15-17

Adis International

Access to resources Recommend Favorite

Effects of growth hormone deficiency and rhGH replacement therapy on the 6β-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children

By Sinués Blanca Mayayo Esteban Fanlo Ana JR Esteban Bernal María Bocos Pilar Bello Elena Labarta Jose Ferrández-Longás Angel

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 559-564

Springer Publishing Company

Access to resources Recommend Favorite